This content is from: Patents

Survey: In-house counsel on the US patent landscape

Fifty four in-house counsel took our survey on how the US patent pendulum has moved and how the courts and the USPTO have changed

Change to the US patent landscape has been controversial. What one lawyer thinks is a common-sense measure to cut down on bad patents, another might consider a disaster designed to kill innovation in an industry.

As IP in-house counsel consider how legislative reforms, courts conducting hearings remotely because of COVID-19, and the 2020 presidential elections will affect their IP strategies, we wanted to understand how they felt about the state of the US patent landscape.

The 54 in-house lawyers who took our survey weighed in on Andrei Iancu’s appointment to director of the USPTO, the PTAB and where the patent pendulum is swinging.

Section one: Broad concerns

In part one, more lawyers thought President Donald Trump’s views on IP were better for their business than those of the Democratic Party’s Joe Biden, but the majority of respondents said either that they ‘didn’t know’ whose IP views among the two men would be better for their businesses or that neither’s were. And while most counsel said the US is not too patent friendly, they were divided on how the pendulum is swinging. Read more here.

Section two: The courts

In part two, respondents said that they wanted to see more remote hearings in the future and that Delaware was their preferred court to litigate in. Read more here.

Section three: The USPTO

In part three, a large majority of respondents said director Iancu was doing a good job, but there was no clear consensus on the PTAB. Read more here.

The material on this site is for law firms, companies and other IP specialists. It is for information only. Please read our Terms and Conditions and Privacy Notice before using the site. All material subject to strictly enforced copyright laws.

© 2021 Euromoney Institutional Investor PLC. For help please see our FAQs.


Instant access to all of our content. Membership Options | 30 Day Trial